Login to Your Account

Deals And M&A NEWS

SHANGHAI – Sciclone Pharmaceuticals Inc. has secured a deal for China (including Hong Kong, Macau, Taiwan and Vietnam) with Theravance Biopharma Inc., for Vibativ (telavancin), a lipoglycopeptide antibiotic that addresses difficult-to-treat hospital-acquired infections and ventilator-assisted infections.

TOKYO – Japan's National Cancer Center (NCC) and pharma major Takeda Pharmaceutical Co. Ltd. have joined forces to discover and develop cancer drugs in Japan and ensure their quick delivery to patients.
A consortium of some of China's biggest health care players is snapping up trans-Pacific protein therapeutics developer Ambrx Inc. for an undisclosed amount in a bid to accelerate the introduction of innovative, and presumably more profitable, therapies to the Chinese market.
More Deals And M&A Headlines

Cast Your Vote

Has biotech’s bubble burst?: